RVL Pharmaceuticals plc (RVLPQ) Stock Analysis
DELISTED
What happened to RVL Pharmaceuticals plc (RVLPQ) stock?
RVL Pharmaceuticals plc (RVLPQ) no longer trades on public markets. The figures below are historical and are not a current quote.
- Status:
- Delisted — no longer trades
For informational purposes only. Not financial advice. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR
RVL Pharmaceuticals plc (RVLPQ). RVL Pharmaceuticals plc is a specialized drug company focusing on ophthalmic and medical aesthetics solutions, with its primary commercial product being Upneeq for acquired blepharoptosis.
Last analyzed: Jun 14, 2026RVL Pharmaceuticals plc (RVLPQ) Healthcare & Pipeline Overview
RVLPQ OTC Market Information
RVLPQ trades on the OTC Other market tier of OTC Markets.
- OTC Tier: OTC Other
More about this archive record
Can I still buy RVLPQ shares?
No. RVLPQ stopped trading on public markets, so the shares are not available through a broker. Anything you see quoted for RVLPQ elsewhere is historical data, not a live market.
Are the figures on this page current?
No. Every number here is the last value recorded before RVLPQ stopped trading. Nothing on this page updates, and none of it is a current quote.
Why does this page still exist?
Because people still search for what happened to RVL Pharmaceuticals plc. An archived profile that states the delisting plainly is more useful than a dead link — provided it is labelled as history, which is what this page does.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.